Alaunos Therapeutics | ZIOP - Cost Of Sales


Alaunos Therapeutics reported $0 in Cost of Sales for its fiscal quarter ending in September of 2024.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
Amgen USD 1.6B 187M Mar/2026
AstraZeneca USD -204M 3.48B Mar/2026
Baxter International USD 1.81B 587M Mar/2026
Biogen USD 797.5M 302M Mar/2026
Bioline Rx USD 95K 55K Mar/2026
Bristol-Myers Squibb USD 3.86B 1.07B Mar/2026
Celltrion KRW 92.83B 14.59B Mar/2026
Corcept Therapeutics USD 2.88M 338K Mar/2026
Cspc Pharmaceutical CNY 2.11B 173.58M Dec/2025
Curis USD 314K 9.96M Dec/2025
Deva Holding AS TRY 991.13M 182.81M Sep/2023
Divis Laboratories Ltd INR 12.39B 1.76B Mar/2026
Gilead Sciences USD 1.44B 174M Mar/2026
GlaxoSmithKline GBP 1.88B 736M Mar/2026
Incyte USD 104.5M 16.68M Mar/2026
Intrexon USD 1.01M 344K Jun/2024
Ionis Pharmaceuticals USD 3M 5M Mar/2026
J&J USD 8B 67M Jun/2026
Kangmei Pharma CNY 841.45M 271.27M Mar/2026
Karyopharm Therapeutics USD 1.48M 35.95M Dec/2025
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
Laboratorios Farma EUR 186.09M 11.06M Dec/2023
Medical Developments International AUD 7.09M 4.91M Dec/2025
Merck USD 2.94B 380M Mar/2026
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Novartis USD 3.46B 83M Mar/2026
Organigram Holdings CAD 43.39M 13.54M Mar/2026
Pfizer USD 4.59B 1.7B Mar/2026
Pharma Mar EUR 3.66M 116K Mar/2026
PTC Therapeutics USD 39.61M 23.31M Mar/2026
Qiagen NV USD 217.43M 29.65M Dec/2025
Regeneron Pharmaceuticals USD 669.4M 84.8M Mar/2026
Roche Holding CHF 8.48B 4.61B Dec/2025
Sangamo BioSciences 2.42M 1.11M Jun/2024
Sartorius EUR 484.6M 46.6M Mar/2026
Sino Biopharmaceutical CNY 3.08B 589.65M Jun/2025
TG Therapeutics USD 33.51M 4.63M Mar/2026
Tilray USD 164.37M 8.41M Sep/2025
Verastem USD 2.89M 2.88M Dec/2025
Zealand Pharma A/S 410K 5K Jun/2025
Zz Pientze Pharmaceu CNY 1.58B 245.15M Mar/2026